Dzhenefarm SA (manufacturing, primary and secondary packaging, quality control and batch release of medicinal product)

The drug is used as adjunctive therapy for the treatment of partial seizures (with or without secondary generalization) in patients aged 16 years and older with epilepsy.

Dosage form: tablets, film-coated

ATC: N03AX18